Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Aralez Pharmaceuticals Inc.

NASDAQ: ARLZHealthcare / Biotechnology / Canada
0.03-0.01-15.00%Vol 6 765 8001Y Perf -97.02%
Aug 20th, 2018 19:22
BID0.00 ASK0.00
Open0.04 Previous Close0.04
Pre-Market- After-Trading-
 - -%  - -%
Target Price
2.50 
Analyst Rating
— — 0.00
Potencial %
- 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/-75 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/-21 
Growth Ranking
★★ —    -
Insiders Shares Cnt. % 3/6/12M
-/-/-61 
Income Ranking
 —    -
Market Cap (mil)2 
Earnings Rating
Strong Sell
Price Range Ratio 52wk %
0.00 
Earnings Date
22nd Aug 2018

Today's Price Range

0.030.04

 

52wk Range

0.032.98

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Sell
Performance
1 Month
0.00%
3 Months
0.00%
6 Months
-92.31%
1 Year
-97.02%
3 Years
-99.58%
5 Years
-99.54%

Quotes

Name / TickerPriceChg.Chg.%
ARLZ0.03-0.0100-15.00
AAPL165.05-3.4400-2.04
GOOG1 036.50-0.0800-0.01
MSFT105.000.18000.17
XOM75.18-2.4600-3.17
WFC48.70-1.5600-3.10
JNJ143.15-2.2800-1.57
FB140.573.15002.29
GE6.86-0.1500-2.14
JPM100.15-3.1400-3.04
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
0.70
Current Ratio
0.80
Long Term Debt to Total Capital
0.95
Total Debt to Equity
18.04
Interest Coverage
-3.30
Leverage Ratio 111.90
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
81.10
EBIT Margin
-76.10
EBITDA Margin
-45.30
Pre-tax Profit Margin
-116.50
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
6.23
PS Ratios
0.05
Price to Cash Flow
72.90
Price to Free Cash Flow
-0.50
Cash Flow Per Share
-0.31
Price to Tangible Book
-0.01
Book Value per Share
-0.10
Enterprise Value (in ths.)
233 569
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-112.25
ROE last 12 Months
-253.46
Return on Assets (5Y Avg)
-10.54
ROA last 12 Months
-23.31
Return on Capital (5Y Avg)
-30.41
ROC last 12 Months
-28.33
Return on invested Capital Q
-4.69
Return on invested Capital Y
-28.89
Assets Turnover
0.10
Receivables Turnover
1.80
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
57 280
Revenue per Share
0.86
Revenue Growth 3 Years
23.67
Revenue Growth 5 Years
46.55
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q01 2018-0.25-0.29-16.00
Q04 2017-0.34-0.37-8.82
Q03 2017-0.39-0.375.13
Q02 2017-0.41-0.42-2.44
Q01 2017-0.40-0.42-5.00
Q04 2016-0.55-0.3732.73
Q03 2016-0.32-0.320.00
Q02 2016-0.36-0.2725.00
Earnings Per EndEstimateRevision %Trend
6/2018 QR-0.28-154.55Negative
9/2018 QR-0.13-1 200.00Negative
12/2018 FY-0.78-13.04Negative
12/2019 FY-0.59-68.57Negative
Next Report Date-
Estimated EPS Next Report-0.28
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume6 765 800
Shares Outstanding (in ths.)67 190
Trades Count2 496
Dollar Volume234 848
Avg. Volume1 607 334
Avg. Weekly Volume6 129 420
Avg. Monthly Volume5 195 370
Avg. Quarterly Volume2 414 323

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

52%48%

Bearish Bullish

52%48%

Bearish Bullish

59%41%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (50.00 %)
1 (50.00 %)
1 (50.00 %)
Moderate Buy
1 (50.00 %)
1 (50.00 %)
1 (50.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Rating---

There are no comments yet.

News